Congo vs Kazakhstan: HIV-positive TB patients on ART (antiretroviral therapy)
Congo
87.0%
in 2024
Kazakhstan
87.0%
in 2024
Congo rank
102nd
Kazakhstan rank
102nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Congo
- Kazakhstan
How they compare
Congo currently reports 87.0% against 87.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 3 times across 18 shared years of data; in 2007 it was Congo ahead.
Congo ranks 102nd and Kazakhstan ranks 102nd of 144 countries.
Across the 3 decades both report, Congo averaged higher in 1 and Kazakhstan in 2.
Head to head by decade
| Decade | Congo | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.3% | 9.6% | 40.7% | Congo |
| 2010s | 35.1% | 65.1% | 30.0% | Kazakhstan |
| 2020s | 72.8% | 91.0% | 18.2% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Congo or Kazakhstan?
- Congo, at 87.0% against 87.0% in Kazakhstan as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Congo and Kazakhstan?
- 0.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Kazakhstan?
- 18 years are reported by both, from 2007 to 2024.
- How do Congo and Kazakhstan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Congo ranks 102nd and Kazakhstan ranks 102nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.